LENZ Therapeutics, Inc. (LENZ) - Latest Market Data

Price & Market Data

Price: $7.88

Daily Change: -$2.11 / 26.78%

Daily Range: $6.84 - $9.01

Market Cap: $248,013,248

Daily Volume: 2,346,583

Performance Metrics

1 Week: -12.79%

1 Month: -17.86%

3 Months: -42.09%

6 Months: -65.56%

1 Year: -73.07%

YTD: -50.56%

About LENZ Therapeutics, Inc. (LENZ)

Discover the investment profile of LENZ Therapeutics, Inc. (LENZ). With a price of 7.88, and a daily change of -$2.11 / 26.78%. Market cap: 248,013,248. Performance figures include YTD and 52-week returns.

Company Details

Employees: 152

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Selected stocks

CompX International Inc. (CIX)

Lesaka Technologies, Inc. (LSAK)

Micron Technology, Inc. (MU)

Liberty Media Corporation - Series C Liberty Formula One (FWONK)